Guangzhou State Key Laboratory of Respiratory Diseases explores new immunization therapy against emerging infectious diseases

Jul 5, 2013

The procedure is based on chimeric monoclonal antibodies where variable regions are derived from newly infected macaque lymphocytes. The procedure was succesfully tested with H5N1 avian flue virus subtypes.

Weixu MENG et al., PLoS ONE June 8 (6) : e66276

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny